Forty years of topical beta-blockers

28 February 2020
Volume 21, Issue 1

This article reviews the use of topical beta-blockers for the treatment of glaucoma.

Although beta-blockers are no longer first choice for the treatment for glaucoma, they maintain a place in the treatment pathway. This article reviews the history and contemporary use of topical beta-blockers, and considers the range of alternative medical, laser and minimally invasive surgical options for glaucoma.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Which elements are key to the process of shared decision-making between clinician and patient? Georgina Wintersgill reports.

These are designed to support providers in developing qualifications to meet the GOC’s Education and Training Requirements for therapeutic prescribing contact lens specialisms.

This online therapeutics peer review session is open to College members who are qualified independent prescribers or studying for an IP qualification.